Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-000301
Filing Date
2017-03-17
Accepted
2017-03-17 16:29:01
Documents
1
Period of Report
2017-03-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4278.html 4  
1 PRIMARY DOCUMENT doc4_4278.xml 4 7097
  Complete submission text file 0001638599-17-000301.txt   8695
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOSCIENCE, INC. 373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD CO 80112
Business Address
Donofrio John Jr. (Reporting) CIK: 0001679841 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53121 | Film No.: 17698423